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the probability that a child would develop dental caries; the probability that a child with dental caries receives treatment; the probability of receiving dental treatment in hospital; and the average effectiveness of fluoride varnish.
Study designs and other criteria for inclusion in the review
The probability of dental caries was derived from a cross-sectional study because of the lack of longitudinal studies of dental caries. No other information on study designs and inclusion or exclusion criteria were provided.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Nine studies were included in the review, of which six were used to derive the effectiveness data.
Methods of combining primary studies
For most of the effectiveness data only one study was used. Data from three studies were combined to evaluate the probability of a child with dental caries receiving any dental treatment.
Investigation of differences between primary studies
Results of the review
The probability of a child having any new dental caries between the ages of 9 and 42 months was 0.035 per quarter. The probability of a child receiving dental treatment once caries developed ranged from 0.2 to 19% between the ages of 9 and 42 months.
The probability of receiving dental treatment in hospital was 0.140 between the ages of 12 and 21 months, 0.310 between the ages of 24 and 33 months, and 0.135 between the ages of 36 and 42 months. 14.1% between 6 and 9 months; and 7.4% between 9 and 12 months.
Measure of benefits used in the economic analysis
The summary benefit measure was the number of months without cavities per child. The measure of benefits was based on the effectiveness data.
Direct costs
The quantity/cost boundary adopted was that of the payer. The resource quantities and the costs were not reported separately. The study reported the average costs of FVA, dental treatment in the hospital setting and non-hospital treatment. Adverse events were not considered, since it was assumed that FVA had negligible adverse effects. The application cost was derived from a range of fees that some Medicaid programmes reimburse non-dental providers for FVAs. The midpoint was chosen. The cost of hospital treatment was obtained from the experience of pre-school-aged children enrolled in the Iowa Medicaid Program. Non-hospital costs were derived from a retrospective study. The costs were adjusted for inflation using the medical care component of the Consumer Price Index to reflect the 2003 US$ value. The costs were then deflated by 30% to reflect average Medicaid reimbursement fees as a proportion of estimated charges. The costs were discounted at an annual rate of 3%, as recommended by a panel on cost-effectiveness in health and medicine. This was appropriate given that the costs were incurred during more than two years.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included in the analysis.
Currency
US dollars ($).
Sensitivity analysis
A one-way sensitivity analysis was conducted to test the robustness of the results. The parameters varied were the frequency and effectiveness of FVA, the probability of dental caries, the probability of receiving treatment or receiving treatment in the hospital, and the costs (hospital, non-hospital and the discount rate). A two-way sensitivity analysis was conducted to illustrate the joint effect of changing the probability of receiving treatment and non-hospital costs and to vary both the effectiveness of fluoride varnish and the probability of children with dental caries seeking treatment.
Estimated benefits used in the economic analysis
FVA was associated with 31.49 cavity-free months between the ages of 9 and 42 months, compared with 29.97 cavityfree months with no FVA. The incremental effectiveness was 1.52 cavity-free months.
The average number of treatments per child up to the age of 42 months was 0.125 with FVA and 0.179 with no FVA. The incremental effectiveness was 0.054.
Cost results
The cost of FVA was $181.66. The cost of no FVA was $170.73. FVA was associated with an additional cost of $10.93 per child between the ages of 9 and 42 months.
Restorative treatment costs were reduced by $52.00 with FVA, although the application costs of fluoride varnish were $64.00.
Synthesis of costs and benefits
The cost and effectiveness data were combined as incremental cost-effectiveness ratios. FVA resulted in an incremental cost per cavity-free month of $7.18 and an incremental cost per treatment averted of $203.00. The results were shown to be sensitive.
The sensitivity analysis revealed that FVA resulted in lower total costs when fluoride varnish effectiveness was 1.25 times greater, when non-hospital costs were doubled, and when hospital costs were 1.5 times greater than the base-case. The total cost of FVA was lower when the probability of receiving restorative treatment was 1.5 times greater, the likelihood of treatment occurring in the hospital was 1.5 times greater than the baseline case, and cavitation rates were nearly doubled. Increasing the number of applications of fluoride varnish from 4 to 6 between 9 and 42 months increased the effectiveness to 1.87 cavity-free months compared with no FVA, but with an incremental costeffectiveness ratio of $15.59 per cavity-free month gained.
The two-way sensitivity analysis revealed that FVA was cost-saving when increased numbers of children received dental treatment and non-hospital costs doubled from base-case. When the effectiveness of fluoride varnish fell below twothirds of the base-case, FVA was found not to save money despite the increased use of dental treatment.
of dental emergency services and increased caregiver productivity by postponing or diminishing time away from work, were not included. The authors noted the limiting effect of these omissions. The study would have benefited had more information been provided on what resources were included in the costs. The costs and the quantities were not reported separately, which may limit the reproducibility of the results. A thorough sensitivity analysis was undertaken to assess the robustness of the results when the estimated costs were modified. The authors discounted the costs at a rate of 3% based on guidance from a panel on cost-effectiveness in health and medicine, which was appropriate. The date to which the prices referred was reported, which aids future reflation exercises.
